Blonanserin - CAS 132810-10-7

Blonanserin (AD-5423) is an atypical antipsychotic approved in Japan in January, 2008. Relative to many other antipsychotics, blonanserin has an improved tolerability profile, lacking side effects such as extrapyramidal symptoms, excessive sedation, or hypotension.

Sigma receptor, 5-HT Receptor, Dopamine Receptor, Adrenergic Receptor

GPCR/G Protein, Neuroscience

132793

>99.99%

C23H30FN3

367.5

FC1=CC=C(C2=C3C(=NC(=C2)N4CCN(CC)CC4)CCCCCC3)C=C1

-20°C

Ice Packs

Small Compound